Sep 9, 2025 9:20am EDT Capricor Therapeutics Responds to FDA Posting of Complete Response Letter (CRL) for Deramiocel
Aug 18, 2025 9:00am EDT Capricor Therapeutics Announces First Subjects Dosed in Phase 1 Clinical Trial of Novel Exosome-Based Vaccine
Aug 11, 2025 4:30 pm EDT Capricor Therapeutics Second Quarter 2025 Financial Results and Corporate Update Conference Call